Soumit Roy
Stock Analyst at Jones Trading
(3.51)
# 883
Out of 5,147 analysts
46
Total ratings
34.29%
Success rate
12.85%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Soumit Roy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WHWK Whitehawk Therapeutics | Initiates: Buy | $7 | $3.51 | +99.43% | 1 | Dec 22, 2025 | |
| CNTX Context Therapeutics | Initiates: Buy | $7 | $2.25 | +211.11% | 1 | Dec 22, 2025 | |
| EVAX Evaxion | Initiates: Buy | $10 | $3.19 | +213.48% | 1 | Oct 30, 2025 | |
| AVXL Anavex Life Sciences | Downgrades: Hold | n/a | $4.43 | - | 1 | Oct 24, 2025 | |
| ATYR aTyr Pharma | Downgrades: Hold | n/a | $0.96 | - | 2 | Sep 15, 2025 | |
| CGON CG Oncology | Initiates: Buy | $50 | $58.80 | -14.97% | 1 | Sep 8, 2025 | |
| TARA Protara Therapeutics | Initiates: Buy | $21 | $6.36 | +230.19% | 1 | May 22, 2025 | |
| AVBP ArriVent BioPharma | Initiates: Buy | $40 | $22.97 | +74.14% | 1 | May 20, 2025 | |
| ELVN Enliven Therapeutics | Maintains: Buy | $36 → $27 | $29.69 | -9.06% | 2 | May 16, 2025 | |
| ACRV Acrivon Therapeutics | Downgrades: Hold | n/a | $1.51 | - | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.13 | - | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 | $3.99 | +275.94% | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $5.91 | +69.20% | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $34 | $28.46 | +19.47% | 2 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $36 | $1.70 | +2,017.65% | 4 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $2.71 | +1,080.81% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $12.99 | -30.72% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $13.45 | +26.39% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $2.20 | +490.91% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $96 → $64 | $7.25 | +782.76% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.28 | - | 2 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.52 | - | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $26 | $15.50 | +67.74% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $13.61 | +414.33% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $10 | $54.81 | -81.75% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.57 | - | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $12.04 | +564.73% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.05 | - | 2 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $320 | $0.54 | +59,093.49% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $810 | $4.20 | +19,185.71% | 1 | Feb 24, 2021 |
Whitehawk Therapeutics
Dec 22, 2025
Initiates: Buy
Price Target: $7
Current: $3.51
Upside: +99.43%
Context Therapeutics
Dec 22, 2025
Initiates: Buy
Price Target: $7
Current: $2.25
Upside: +211.11%
Evaxion
Oct 30, 2025
Initiates: Buy
Price Target: $10
Current: $3.19
Upside: +213.48%
Anavex Life Sciences
Oct 24, 2025
Downgrades: Hold
Price Target: n/a
Current: $4.43
Upside: -
aTyr Pharma
Sep 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.96
Upside: -
CG Oncology
Sep 8, 2025
Initiates: Buy
Price Target: $50
Current: $58.80
Upside: -14.97%
Protara Therapeutics
May 22, 2025
Initiates: Buy
Price Target: $21
Current: $6.36
Upside: +230.19%
ArriVent BioPharma
May 20, 2025
Initiates: Buy
Price Target: $40
Current: $22.97
Upside: +74.14%
Enliven Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $36 → $27
Current: $29.69
Upside: -9.06%
Acrivon Therapeutics
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.51
Upside: -
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.13
Upside: -
Mar 13, 2025
Upgrades: Buy
Price Target: $15
Current: $3.99
Upside: +275.94%
Mar 12, 2025
Initiates: Buy
Price Target: $10
Current: $5.91
Upside: +69.20%
Mar 10, 2025
Upgrades: Buy
Price Target: $34
Current: $28.46
Upside: +19.47%
Feb 11, 2025
Upgrades: Buy
Price Target: $36
Current: $1.70
Upside: +2,017.65%
Jan 28, 2025
Initiates: Buy
Price Target: $32
Current: $2.71
Upside: +1,080.81%
Oct 31, 2024
Initiates: Buy
Price Target: $9
Current: $12.99
Upside: -30.72%
Oct 31, 2024
Initiates: Buy
Price Target: $17
Current: $13.45
Upside: +26.39%
Sep 17, 2024
Initiates: Buy
Price Target: $13
Current: $2.20
Upside: +490.91%
Sep 11, 2024
Maintains: Buy
Price Target: $96 → $64
Current: $7.25
Upside: +782.76%
Jul 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.28
Upside: -
May 15, 2024
Downgrades: Hold
Price Target: n/a
Current: $4.52
Upside: -
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $15.50
Upside: +67.74%
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $13.61
Upside: +414.33%
Apr 11, 2024
Upgrades: Buy
Price Target: $10
Current: $54.81
Upside: -81.75%
May 23, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.57
Upside: -
Apr 19, 2023
Initiates: Buy
Price Target: $80
Current: $12.04
Upside: +564.73%
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $2.05
Upside: -
Nov 8, 2022
Initiates: Buy
Price Target: $320
Current: $0.54
Upside: +59,093.49%
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $4.20
Upside: +19,185.71%